446 related articles for article (PubMed ID: 16049343)
1. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.
Al-Shabrawey M; Bartoli M; El-Remessy AB; Platt DH; Matragoon S; Behzadian MA; Caldwell RW; Caldwell RB
Am J Pathol; 2005 Aug; 167(2):599-607. PubMed ID: 16049343
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
Saito Y; Geisen P; Uppal A; Hartnett ME
Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
[TBL] [Abstract][Full Text] [Related]
3. NAD(P)H oxidase-dependent regulation of CCL2 production during retinal inflammation.
Zhang W; Rojas M; Lilly B; Tsai NT; Lemtalsi T; Liou GI; Caldwell RW; Caldwell RB
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):3033-40. PubMed ID: 19234337
[TBL] [Abstract][Full Text] [Related]
4. NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells.
Duerrschmidt N; Stielow C; Muller G; Pagano PJ; Morawietz H
J Physiol; 2006 Oct; 576(Pt 2):557-67. PubMed ID: 16873416
[TBL] [Abstract][Full Text] [Related]
5. Suppression of retinal peroxisome proliferator-activated receptor gamma in experimental diabetes and oxygen-induced retinopathy: role of NADPH oxidase.
Tawfik A; Sanders T; Kahook K; Akeel S; Elmarakby A; Al-Shabrawey M
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):878-84. PubMed ID: 18806296
[TBL] [Abstract][Full Text] [Related]
6. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Nox2 NADPH oxidase in retinal neovascularization.
Chan EC; van Wijngaarden P; Liu GS; Jiang F; Peshavariya H; Dusting GJ
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):7061-7. PubMed ID: 24106122
[TBL] [Abstract][Full Text] [Related]
9. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
Li L; Renier G
Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
[TBL] [Abstract][Full Text] [Related]
10. Role of NADPH oxidase in retinal vascular inflammation.
Al-Shabrawey M; Rojas M; Sanders T; Behzadian A; El-Remessy A; Bartoli M; Parpia AK; Liou G; Caldwell RB
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3239-44. PubMed ID: 18378574
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate acid inhibits endothelial NAD(P)H oxidase activity and superoxide formation by a Rac1-dependent mechanism.
Krötz F; Keller M; Derflinger S; Schmid H; Gloe T; Bassermann F; Duyster J; Cohen CD; Schuhmann C; Klauss V; Pohl U; Stempfle HU; Sohn HY
Hypertension; 2007 Jan; 49(1):201-8. PubMed ID: 17101842
[TBL] [Abstract][Full Text] [Related]
12. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.
Tojo T; Ushio-Fukai M; Yamaoka-Tojo M; Ikeda S; Patrushev N; Alexander RW
Circulation; 2005 May; 111(18):2347-55. PubMed ID: 15867174
[TBL] [Abstract][Full Text] [Related]
13. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
Aiello LP; Pierce EA; Foley ED; Takagi H; Chen H; Riddle L; Ferrara N; King GL; Smith LE
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10457-61. PubMed ID: 7479819
[TBL] [Abstract][Full Text] [Related]
14. Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.
Saito Y; Uppal A; Byfield G; Budd S; Hartnett ME
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1591-8. PubMed ID: 18385079
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.
Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.
Zhao S; Huang L; Wu J; Zhang Y; Pan D; Liu X
Mol Vis; 2009 Jun; 15():1231-42. PubMed ID: 19536308
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H oxidase-stimulating activity of serum from type 2 diabetic patients with retinopathy mediates enhanced endothelial expression of E-selectin.
Yun MR; Im DS; Lee JS; Son SM; Sung SM; Bae SS; Kim CD
Life Sci; 2006 Apr; 78(22):2608-14. PubMed ID: 16343554
[TBL] [Abstract][Full Text] [Related]
18. Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization.
Hu J; Song X; He YQ; Freeman C; Parish CR; Yuan L; Yu H; Tang S
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6810-7. PubMed ID: 22956610
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
Xu Z; Yu Y; Duh EJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4059-66. PubMed ID: 16936124
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats.
Angermayr B; Fernandez M; Mejias M; Gracia-Sancho J; Garcia-Pagan JC; Bosch J
Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
